Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: A retrospective review

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 5, 1999, Pages 1053-1056

  Nguyen, Linh N ^a   Komaki, Ritsuko ^a   Allen, Pamela ^a   Schea, Randi A ^a   Milas, Luka ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Accelerated radiation therapy; Inoperable; Nonsmall cell lung cancer; Poor prognostic factors

Indexed keywords

ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0032776199     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00130-3     Document Type: Article

References (17)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1997. CA Cancer J Clin. 47:1997;5-27.
2. Komaki R., Scott C.B., Sause W.T., et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer Failure patterns by cell type in RTOG 88-08/ECOG 4588 . Int J Radiat Oncol Biol Phys. 39:1997;537-544.
3. Perez C.A., Stanley K., Grundy G., et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung Report by the RTOG . Cancer. 50:1982;1091-1099.
4. American Joint Committee on Cancer (AJCC). Manual for staging of cancer. 4th ed. (Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds.). Philadelphia: J.B. Lippincott; 1992. p. 117-122.
5. Petrovich Z., Stanley K., Cox J.D., Paig C. Radiotherapy in the management of locally advanced lung cancer of all cell types Final report of a randomized trial . Cancer. 48:1981;1335-1340.
6. Stanley K.E. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst. 65:1980;25-32.
7. Dillman R.O., Stephen S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 323:1990;940-945.
8. Cox J.D., Azarnia N., Byhardt R.W., et al. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with >69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol. 8:1990;1543-1555.
9. Wigren T., Kellokumpu-Lehtinen P., Ojala A. Radical radiotherapy of inoperable non-small cell lung cancer. Acta Oncol. 31:1992;555-561.
10. Trovo M.G., Minatel E., Veronesi A., et al. Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma A randomized study . Cancer. 65:1990;400-404.
11. Hall E.J. Cell survival curves. Hall E.J. Radiobiology for the radiologist. 4th ed. 1994;29-43 J.B. Lippincott, Philadelphia.
12. Duchenne G., Peacock J., Steel G. The acute in vitro and in vivo radiosensitivity of human lung tumour lines. Radiother Oncol. 7:1986;353-361.
13. Morstyn G., Russo A., Carney D., et al. Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell lines. J Natl Cancer Inst. 73:1984;801-807.
14. Brodin O., Lennartsson L., Nilsson S. Single-dose and fractionated irradiation of four human lung cancer cell lines in vitro. Acta Oncol. 30:1991;967-974.
15. Withers H.R., Maciejewski B., Taylor J.M.G., Hliniak A. Accelerated repopulation in head and neck cancer. Front Radiat Ther Oncol. 22:1988;105-110.
16. Turrisi A.T. III, Kim K., Blum R., Sause W.T., Livingston R.B., Komaki R., Wagner H., Aisner S., Johnson D.H. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 340:1999;265-271.
17. Saunders M.I., Dische S., Barrett A., Parmar M.K.B., Harvey A., Gibson D. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer An interim report . Br J Cancer. 15:1996;1455-1462.